Much current interest in IL-33 has been prompted by its role in several inflammatory and autoimmune diseases including SLE, Sjögren’s syndrome, systemic sclerosis and rheumatoid arthritis [21,22,23,24]. This evidence concerns the gene IL33 and systemic lupus erythematosus.